BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. (BMRN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BMRN · as of Jun 8, 2026
Key Statistics
Explore BioMarin Pharmaceutical Inc. Data
bmrn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 41 · Buy rate: 68.3%
The BMRN analyst consensus is Buy, based on ratings from 41 Wall Street analysts over the past 3 months. The average 12-month price target is $89.93, representing +58.41% upside from the current price of $56.77.
Competitors & Peers
bmrn competitorsBMRN
ALGN
BBIO
EXEL
HALO
MDGLStock Performance
Full HistoryAbout BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme…
what is biomarin pharmaceutical inc. · bmrn stock overview · biomarin pharmaceutical inc. company profile · who is biomarin pharmaceutical inc. ceo · bmrn NASDAQ · biomarin pharmaceutical inc. headquarters · biomarin pharmaceutical inc. business segments
About Stock Overview & Key Data
BioMarin Pharmaceutical Inc. (BMRN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 26, 1999. As of the latest trading session, BMRN stock price is $56.77, with a market capitalization of $11.0B. The stock has returned -0.19% over the past 12 months and -4.48% year-to-date.
According to 41 Wall Street analysts, the consensus rating for BioMarin Pharmaceutical Inc. stock is Buy, with an average 12-month price target of $89.93. In fiscal year 2025, BioMarin Pharmaceutical Inc. reported revenue of $3.2B and net income of $348.9M. For detailed data — including BioMarin Pharmaceutical Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, BioMarin Pharmaceutical Inc. (BMRN) stock price is $56.77. The stock is traded on NASDAQ under the ticker symbol BMRN. The 52-week range is $49.26 – $66.28.